CFTR and cystic fibrosis: Rabbits treated with this regimen had a median age of survival > 80 days (Figure 1A), suggesting that medical therapy can alleviate intestinal disease in CF rabbits and extend their lifespan as compared with other large CF animal models, where surgical or transgenic correction of the CFTR defect is required to overcome early mortality (10, 27, 29).